Robert E. Glasgow

Robert E. Glasgow, MD, MBA

Languages spoken: English

  • After graduating with a Bachelor of Science from Stanford University and Doctor of Medicine from the University of California, San Francisco, Dr. Glasgow completed a General Surgery Residency and Research Fellowship in Gastrointestinal Surgery at the University of California, San Francisco then a Fellowship in Advanced Minimally Invasive and Gastrointestinal Surgery at Legacy Health System in Portland, Oregon. He is also a 2020 graduate from the Executive MBA program at the David Eccles School of Business at the University of Utah.

    Dr. Glasgow's clinical focus is in the area of gastrointestinal surgery with a special emphasis on minimally invasive techniques in the management of gastroesophageal and upper gastrointestinal disorders. Dr. Glasgow specializes in the treatment of benign and malignant disorders of the esophagus, stomach, intestines, liver, gallbladder, pancreas and biliary tree. He is also an expert in the minimally invasive treatment of hernia disease, including abdominal wall and groin hernias as well as hiatal hernias.

    Dr. Glasgow's research and administrative interests are in the area of clinical operations and optimization of quality and value in surgical care with the goal of maintaining University of Utah Health at the highest level of surgical care in the country.

    Specialties

    Board Certification

    American Board of Surgery (Sub: General Surgery)

  • After graduating with a Bachelor of Science from Stanford University and Doctor of Medicine from the University of California, San Francisco, Dr. Glasgow completed a General Surgery Residency and Research Fellowship in Gastrointestinal Surgery at the University of California, San Francisco then a Fellowship in Advanced Minimally Invasive and Gastrointestinal Surgery at Legacy Health System in Portland, Oregon. He is also a 2020 graduate from the Executive MBA program at the David Eccles School of Business at the University of Utah.

    Dr. Glasgow's clinical focus is in the area of gastrointestinal surgery with a special emphasis on minimally invasive techniques in the management of gastroesophageal and upper gastrointestinal disorders. Dr. Glasgow specializes in the treatment of benign and malignant disorders of the esophagus, stomach, intestines, liver, gallbladder, pancreas and biliary tree. He is also an expert in the minimally invasive treatment of hernia disease, including abdominal wall and groin hernias as well as hiatal hernias.

    Dr. Glasgow's research and administrative interests are in the area of clinical operations and optimization of quality and value in surgical care with the goal of maintaining University of Utah Health at the highest level of surgical care in the country.

    Board Certification and Academic Information

    Academic Departments Surgery -Adjunct
    Academic Divisions General Surgery
    Board Certification
    American Board of Surgery (Sub: General Surgery)

    Education history

    Graduate Training University of Utah Executive M.B.A.
    Minimally Invasive Gastrointestinal Surgery - Legacy Health System Fellow
    Chief Resident General Surgery - University of California - San Francisco Chief Resident
    Gastrointestinal Surgery - University of California - San Francisco Research Fellow
    Residency Surgery - University of California - San Francisco Resident
    Surgery - University of California - San Francisco Intern
    Professional Medical Medicine - University of California - San Francisco M.D.
    Biological Sciences - Stanford University B.S.

    Selected Publications

    Journal Article

    1. Leeflang E, Madden J, Ibele A, Glasgow R, Morrow E (2021). Laparoscopic management of symptomatic congenital diaphragmatic hernia of Morgagni in the adult. Surg Endosc, 36(1), 216-221.
    2. Glasgow RE, Mulvihill SJ, Pettit JC, Young J, Smith BK, Vargo DJ, Ray DM, Finlayson SRG (2021). Value Analysis of Methods of Inguinal Hernia Repair. Ann Surg, 274(4), 572-580.
    3. Bleicher J, Stokes SM, Brooke BS, Glasgow RE, Huang LC (2021). Patient-centered Opioid Prescribing: Breaking Away From One-Size-Fits-All Prescribing Guidelines. J Surg Res, 264, 1-7.
    4. Parsons M, Lloyd S, Johnson S, Scaife C, Varghese T, Glasgow R, Garrido-Laguna I, Tao R (2020). Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival. Ann Surg Oncol, 28(2), 663-675.
    5. Pender T, Boi L, Urbik VM, Glasgow R, Smith BK (2020). Implementation and Evaluation of a Novel High-Value Care Curriculum in a Single Academic Surgery Department. J Am Coll Surg, 232(1), 81-90.
    6. Stokes SM, Scaife CL, Brooke BS, Glasgow RE, Mulvihill SJ, Finlayson SRG, Varghese TK Jr (2020). Hospital Costs Following Surgical Complications: A Value-driven Outcomes Analysis of Cost Savings Due to Complication Prevention. Ann Surg, 275, e375-e381.
    7. Morrow E, Chang JW, Biber J, Miller M, McGarrity L, Glasgow R, Volckmann E, Ibele A, Brooke B (2020). Prospective Collection of PROMIS Physical Function Measure Demonstrates Significant Improvement After Bariatric Surgery. Obes Surg, 30(5), 1898-1903.
    8. Stokes SM, Kim RY, Jacobs A, Esplin J, Kwok AC, Varghese TK Jr, Glasgow RE, Brooke BS, Finlayson SRG, Huang LC (2019). Home Disposal Kits for Leftover Opioid Medications After Surgery: Do They Work? J Surg Res, 245, 396-402.
    9. Liu JB, Pusic AL, Hall BL, Glasgow RE, Ko CY, Temple LK (2018). Combining Surgical Outcomes and Patient Experiences to Evaluate Hospital Gastrointestinal Cancer Surgery Quality. J Gastrointest Surg, 23(9), 1900-1910.
    10. Chen J, Miller M, Ibele A, Morrow E, Glasgow R, Volckmann E (2018). Dual Ring Wound Protector Reduces Circular Stapler Related Surgical Site Infections in Patients Undergoing Laparoscopic Roux-En-Y Gastric Bypass. Obes Surg, 28(10), 3352-3359.
    11. Morrow EH, Chen J, Patel R, Bellows B, Nirula R, Glasgow R, Nelson RE (2018). Watchful waiting versus elective repair for asymptomatic and minimally symptomatic paraesophageal hernias: A cost-effectiveness analysis. Am J Surg, 216(4), 760-763.
    12. Nevala-Plagemann C, Francis S, Cavalieri C, Tao R, Whisenant J, Glasgow R, Scaife C, Lloyd S, Garrido-Laguna I (2018). Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. ESMO Open, 3(5), e000386.
    13. Chen J, Presson A, Zhang C, Ray D, Finlayson S, Glasgow R (2018). Online physician review websites poorly correlate to a validated metric of patient satisfaction. J Surg Res, 227, 1-6.
    14. Tonna JE, Kawamoto K, Presson AP, Zhang C, Mone MC, Glasgow RE, Barton RG, Hoidal JR, Anzai Y (2017). Single intervention for a reduction in portable chest radiography (pCXR) in cardiovascular and surgical/trauma ICUs and associated outcomes. J Crit Care, 44, 18-23.
    15. Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, Cluff K, Davis KA, Dellinger EP, Dowdy SC, Duncan K, Fedderson J, Glasgow R, Hall B, Hirsch M, Hutter M, Kimbro L, Kuvshinoff B, Makary M, Morris M, Nehring S, Ramamoorthy S, Scott R, Sovel M, Strong V, Webster A, Wick E, Aguilar JG, Carlson R, Sepkowitz K (2018). Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study. Infect Control Hosp Epidemiol, 19, 1-8.
    16. Gilsdorf D, Volckmann E, Brickley A, Taylor LJ, Glasgow RE, Fang J (2017). Pyloroplasty Offers Relief of Postfundoplication Gastroparesis in Patients Who Improved After Botulinum Toxin Injection. J Laparoendosc Adv Surg Tech A, 27(11), 1180-1184.
    17. Chen J, Mackenzie J, Zhai Y, OLoughlin J, Kholer R, Morrow E, Glasgow R, Volckmann E, Ibele A (2017). Preventing Returns to the Emergency Department FollowingBariatric Surgery. Obes Surg, 27(8), 1986-1992.
    18. Martin L, Presson AP, Zhang C, Ray D, Finlayson S, Glasgow R (2017). Association between surgical patient satisfaction and nonmodifiable factors. J Surg Res, 214, 247-253.
    19. Chen J, Jensen CR, Manwaring PK, Glasgow RE (2017). Validation of a Laparoscopic Ferromagnetic Technology-based Vessel Sealing Device and Comparative Study to Ultrasonic and Bipolar Laparoscopic Devices. Surg Laparosc Endosc Percutan Tech, 27(2), e12-e17.
    20. Chen J, Manwaring PK, Scott RR, Manwaring KH, Glasgow RE (2015). Ferromagnetic Heating for Vessel Sealing and Division: Utility and Comparative Study to Ultrasonic and Bipolar Technologies. Surg Innov, 22(4), 329-37.
    21. Norton WE, Hosokawa PW, Henderson WG, Volckmann ET, Pell J, Tomeh MG, Glasgow RE, Min SJ, Neumayer LA, Hawn MT (2014). Acceptability of the decision support for safer surgery tool. Am J Surg, 209(6), 977-84.
    22. Glasgow RE, Hawn MT, Hosokawa PW, Henderson WG, Min SJ, Richman JS, Tomeh MG, Campbell D, Neumayer LA, DS3 Study Group (2013). Comparison of prospective risk estimates for postoperative complications: human vs computer model. J Am Coll Surg, 218(2), 237-45.e1-4.
    23. Scaife CL, Hartz A, Pappas L, Pelletier P, He T, Glasgow RE, Mulvihill SJ (2013). Association between postoperative complications and clinical cancer outcomes. Ann Surg Oncol, 20(13), 4063-6.
    24. Ajani JA, Bentrem DJ, Besh S, DAmico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, et al (2013). Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw, 11(5), 531-46.
    25. Jackson KL, Glasgow RE, Hill, BR, Mone MC, Sklow B, Scaife CL, Sheng X, Peche WJ (2013). Does Travel Distance Influence Length of Stay in Elective Colorectal Surgery? Dis Colon Rectum, 56(3), 367-73.
    26. Mawhinney MR, Glasgow RE (2012). Current treatment options for management of oesophageal cancer: a review. Cancer Manag Res, 4, 367-377.
    27. Pearson EG, Scaife CL, Mulvihill SJ, Glasgow RE (2011). Roux-en-Y drainage of a pancreatic fistula for disconnected pancreatic duct syndrome after acute necrotizing pancreatitis. HPB (Oxford), 14(1), 26-31.
    28. Mawhinney MR, Glasgow RE (2012). Current treatment options for the management of esophageal cancer. Cancer Manag Res, 4, 367-77.
    29. Gross ME, Nelson ET, Mone MC, Hansen HJ, Sklow B, Glasgow RE, Scaife CL (2011). A comparison of postoperative outcomes utilizing a continuous preperitoneal infusion versus epidural for midline laparotomy. Am J Surg, 202(6), 765-9; discussion 770.
    30. Maxwell CI, Hilden K, Glasgow RE, Ollerenshaw J, Carlisle JG, Fang JC (2011). Evaluation of gastropexy and stoma tract maturation using a novel introducer kit for percutaneous gastrostomy in a porcine model. JPEN J Parenter Enteral Nutr, 35(5), 630-5.
    31. Glasgow RE, Ilson DH, Hayman JA, Gerdes H, Mulcahy MF, Ajani JA (2011). Modern treatment of localized esophageal cancer. J Natl Compr Canc Netw, 9(8), 902-11.
    32. Glasgow RE, Ilson DH, Hayman JA, Gerdes H, Mulcahy MF, Ajani JA (2011). Modern approaches to localized cancer of the esophagus. J Natl Compr Canc Netw, 9(8), 902-11.
    33. Bair RJ, Weis JR, Clayton F, Glasgow RE, Gaffney DK (2010). Palliative chemoradiation in advanced hepatocellular carcinoma. J Clin Oncol, 28(15), e231-2.
    34. Glasgow RE, Jackson HH, Neumayer L, Schifftner TL, Khuri SF, Henderson WG, Mulvihill SJ (2007). Pancreatic resection in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg, 204(6), 1252-60.
    35. Reuben BC, Stoddard G, Glasgow R, Neumayer LA (2007). Trends and predictors for vagotomy when performing oversew of acute bleeding duodenal ulcer in the United States. J Gastrointest Surg, 11(1), 22-8.
    36. Rollins MD, Sudarshan S, Firpo MA, Etherington BH, Hart BJ, Jackson HH, Jackson JD, Emerson LL, Yang DT, Mulvihill SJ, Glasgow RE (2006). Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. J Gastrointest Surg, 10(8), 1120-30.
    37. Granger SR, Rollins MD, Mulvihill SJ, Glasgow RE (2006). Lessons learned from laparoscopic treatment of gastric and gastroesophageal junction stromal cell tumors. Surg Endosc, 20(8), 1299-304.
    38. Granger SR, Glasgow RE, Battaglia J, Lee RM, Scaife C, Shrieve DC, Avrin D, Mulvihill SJ (2005). Development of a dedicated hepatopancreaticobiliary program in a university hospital system. J Gastrointest Surg, 9(7), 891-5.
    39. Firpo MA, Rollins MD, Szabo A, Gull JD, Jackson JD, Shao Y, Glasgow RE, Mulvihill SJ (2005). A conscious mouse model of gastric ileus using clinically relevant endpoints. BMC Gastroenterol, 5(1), 18.
    40. Hatch KF, Daily MF, Christensen BJ, Glasgow RE (2004). Failed fundoplications. Am J Surg, 188(6), 786-91.
    41. Glasgow RE, Adamson KA, Mulvihill SJ (2004). The benefits of a dedicated minimally invasive surgery program to academic general surgery practice. J Gastrointest Surg, 8(7), 869-73; discussion 873-5.
    42. Lightner AM, Glasgow RE, Jordan TH, Krassner AD, Way LW, Mulvihill SJ, Kirkwood KS (2004). Pancreatic resection in the elderly. J Am Coll Surg, 198(5), 697-706.
    43. Jackson HH, Jackson JD, Mulvihill SJ, Firpo MA, Glasgow RE (2004). Trends in research support and productivity in the changing environment of academic surgery. J Surg Res, 116(2), 197-201.
    44. Cheng J, Glasgow RE, ORourke RW, Swanstrom LL, Hansen PD (2003). Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc, 17(1), 61-7.
    45. Glasgow RE, Fingerhut A, Hunter JG (2003). SAGES Appropriateness Conference; 2002 World Congress of Endoscopic Surgery. Surg Endosc, 17(11), 1729-34.
    46. Visser BC, Glasgow RE, Mulvihill KK, Mulvihill SJ (2001). Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg, 18(5), 409-17.
    47. Glasgow RE, Cho M, Hutter MM, Mulvihill SJ (2000). The spectrum and cost of complicated gallstone disease in California. Arch Surg, 135(9), 1021-5; discussion 1025-7.
    48. Hutter MM, Glasgow RE, Mulvihill SJ (2000). Does the participation of a surgical trainee adversely impact patient outcomes? A study of major pancreatic resections in California. Surgery, 128(2), 286-92.
    49. Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ (1999). The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg, 134(1), 30-5.
    50. Patti MG, Corvera CU, Glasgow RE, Way LW (1998). A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg, 2(2), 186-92.
    51. Glasgow RE, Visser BC, Harris HW, Patti MG, Kilpatrick SJ, Mulvihill SJ (1998). Changing management of gallstone disease during pregnancy. Surg Endosc, 12(3), 241-6.
    52. Glasgow RE, Mulvihill SJ (1996). Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med, 165(5), 294-300.

    Review

    1. Chen J, Glasgow RE (2022). What is the Best Inguinal Hernia Repair? [Review]. Adv Surg, 56(1), 247-258.
    2. Glasgow RE, Mulvihill SJ (1997). Post-gastrectomy syndromes. [Review]. 14(3), 132-152.

    Book Chapter

    1. Glasgow RE, Mulvihill SJ (2010). Treatment of gallstone disease. In Feldman M, Scharschmidt BF, Sleisenger MH (Eds.), Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (9th Edition, pp. 1121-39). Philadelphia: WB Saunders.
    2. Glasgow RE, Mulvihill SJ (2009). Surgery for Peptic Ulcer Disease and Postgastrectomy Syndromes. In Yamada, T (Eds.), Textbook of Gastroenterology (5th Edition, pp. 1054-71). Oxford: Wiley-Blackwell Publishing.

    Case Report

    1. Gutnik L, Goold E, Madsen J, Clayton F, Varghese T, Glasgow R (2020). Primary Esophageal Angiosarcoma. Ann Thorac Surg, 111(5), e365-e367.

    Abstract

    1. Jacobs A, Stokes S, Huang LC, Glasgow RE, Brooke BS (2019). Brief educational intervention at discharge reduces opioid use and increases disposal after vascular surgery [Abstract]. 229(4 (Supplement 1)), S325.

    Other

    1. Glasgow RE, Fingerhut A, Hunter J, SAGES (2003). SAGES Appropriateness Conference: a summary. Surg Endosc (17(11), pp. 1729-34). Germany.

    Video/Film/CD/Web/Podcast

    1. Glasgow RE, Finlayson SF, Ray DM (2018). To Enlist Physicians in Reducing Costs, Show Them the Costs [Web]. Boston: Harvard Business Review. Available: https://hbr.org/2018/05/to-enlist-physicians-in-reducing-costs-show-them-the-costs.

  • Podcasts & News

    News